Navigation Links
Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting
Date:12/9/2008

Findings confirm advantages of fixed-ratio drug delivery and lay the groundwork for Phase 2 trials already underway in first-line and first-relapse Acute Myeloid Leukemia (AML) settings

PRINCETON, N.J., Dec. 9 /PRNewswire/ -- Celator Pharmaceuticals today announced that a Phase 1 dose escalating study of CPX-351 (cytarabine:daunorubicin) Liposome Injection established the recommended dose for Phase 2 studies and confirmed preliminary observations of safety, enhanced pharmacokinetics and promising anti-tumor activity in patients with advanced leukemia. A final analysis of the Phase 1 data (abstract #2984) and supportive findings from a pre-clinical pharmacodynamic model (abstract #942) were presented at the 50th American Society of Hematology (ASH) Annual Meeting in San Francisco.

"In the Phase 1 trial, CPX-351 had a tolerability profile that appears better than conventional cytarabine/daunorubicin treatment and produced impressive anti-leukemic responses, including complete remissions (CRs) at and below the maximum tolerated dose, in relapsed and refractory patients," said Eric J. Feldman, MD, of the Weill Medical College of Cornell University and New York-Presbyterian Hospital, the principal investigator in the study. "These encouraging results suggest that CPX-351 may offer advantages to conventional administration of these commonly used drugs. We are excited to participate in the two Phase 2 studies."

In the study, complete remissions were observed in 11 of 47 patients, including 10 patients (9 CRs and 1 CRp - complete remission without full platelet recovery) of 44 with AML and 1 patient of 3 with acute lymphocytic leukemia (ALL) following treatment with CPX-351. Of the 10 AML CRs, 7 occurred at the two highest dose levels, although complete remissions were achieved at dose levels as little as one third of the maximum tolerated dose (MTD). Of note, 7 CRs were achieved in 22 patient
'/>"/>

SOURCE Celator Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Frederick R. Appelbaum, M.D. and Ross C. Donehower, M.D. Join Scientific Advisory Board of Celator(R) Pharmaceuticals
2. Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008
3. Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
4. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
5. ISTA Pharmaceuticals to Participate at the RBC Capital Markets Healthcare Conference
6. Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas
7. Memory Pharmaceuticals Receives NASDAQ Decisions
8. MAP Pharmaceuticals to Present at the 2008 RBC Capital Markets Healthcare Conference
9. The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders
10. Quark Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference
11. Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... (HealthDay News) -- Animals make great companions for senior citizens, ... the car are far more likely to crash than those ... The new study included 2,000 licensed drivers aged 70 and ... how often they drove with their pet in the car. ... crash risk was twice as high as among those who ...
(Date:5/25/2013)... 2013 Absolute Surgical Specialists, serving Sun City ... NALA’s businesses throughout the country participating in Shop Local for ... the nationwide event as he understands what military families go ... Army. He said, “I wanted to give something back, as ... I live here too.” , Shop Local for a Cause ...
(Date:5/25/2013)... On May 25, Voices Against Brain ... advocacy, comments on a new study by the Max ... atmospheric plasma into brain cancer treatment may help when ... Science Daily article, physicists from the Max ... demonstrated the “synergistic effect of cold atmospheric plasma -- ...
(Date:5/25/2013)... 2013 Acuity Games ’ innovative brain ... of Word Hunt is available today, expanding it ... Match, Flash 2, Sudoku and Matchematics will roll out over ... and revolutionary lifetime brain fitness measurement have been re-optimized for ... years of brain fitness measurement in your pocket. What ...
(Date:5/25/2013)... Ayurveda is the traditional medicine of India. ... a medical science, its scope enters into the realms of ... is that disease is the end result of living out ... health, one must discover where we are living out of ... back into perfect harmony. , The Foundations course in Mexico ...
Breaking Medicine News(10 mins):Health News:Seniors More Likely to Crash When Driving With Pet: Study 2Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2Health News:Acuity Games Apps Come to the iPhone 2Health News:Fundamentos de Ayurveda in Mexico (Ayurvedic Principles) Offered by Escuela de Ayurveda de California 2
... peanut butter as salmonella probe widens; Kellog recalls Famous ... sickened, 6 dead, in 43 states and Canada , , ... and Drug Administration on Saturday warned consumers not to ... butter paste, as the investigation into the widespread salmonella ...
... Company,today announced a voluntary recall of certain Austin(R) ... snack-size packs of Famous Amos(R),Peanut Butter Cookies and ... products have the potential to be contaminated with,Salmonella. ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20090116/CLF082 ...
... the condition, study says , , FRIDAY, Jan. 16 (HealthDay ... doctors detect some forms of autism, potentially leading to ... researchers say. , Scientists will need to confirm the ... looked at just 27 people with autism. Follow-up research ...
... N.Y., Jan. 16 KJT Group announces a former Harris ... KJT Group is pleased to announce the appointment of ... A resident of Rochester, Mr. Moller has a BA ... Science in Public Policy Analysis from the University of ...
... that often goes untreated , , FRIDAY, Jan. 16 (HealthDay ... in correctional facilities across the country suffer a much ... general population does, a new report finds. ... the total U.S. population -- also have difficulty accessing ...
... AMERIGROUP Foundation announced today that it is honoring Kim ... Academy, by designating her a "Healthy Hero."Ms. Bearden is ... Clark Academy, a nonprofit school that serves financially vulnerable ... the past two decades, she has won numerous educational ...
Cached Medicine News:Health News:FDA Warns Consumers Not to Eat Peanut Butter Products 2Health News:FDA Warns Consumers Not to Eat Peanut Butter Products 3Health News:FDA Warns Consumers Not to Eat Peanut Butter Products 4Health News:Kellogg Company Announces Voluntary Nationwide Recall of Austin(R) and Keebler(R) Branded Peanut Butter Sandwich Crackers and Select Snack-Size Packs of Famous Amos(R) and Keebler(R) Soft Batch Peanut Butter Cookies Because of Possible Health Risk 2Health News:Kellogg Company Announces Voluntary Nationwide Recall of Austin(R) and Keebler(R) Branded Peanut Butter Sandwich Crackers and Select Snack-Size Packs of Famous Amos(R) and Keebler(R) Soft Batch Peanut Butter Cookies Because of Possible Health Risk 3Health News:Saliva Test Could Indicate Autism 2Health News:KJT Group L.L.C. Continues Solid Growth 2Health News:Many in U.S. Prisons Lack Good Health Care 2Health News:Many in U.S. Prisons Lack Good Health Care 3Health News:Atlanta Educator Kim Bearden Honored as 'Healthy Hero' by AMERIGROUP Foundation 2
(Date:5/23/2013)... , May 23, 2013 More than ... may not benefit from chemotherapy and still have excellent ... launch of one of the largest sources of online ... website and interactive Facebook page provide recently diagnosed women ... can safely avoid chemotherapy. "We anticipate these ...
(Date:5/23/2013)... , May 23, 2013  Hologic, Inc. (Hologic ... a leading developer, manufacturer and supplier of premium ... an emphasis on serving the healthcare needs of ... study in a U.S. clinical practice comparing breast ... tomosynthesis) with conventional 2D mammography alone showed a ...
(Date:5/23/2013)... 2013  BioElectronics Corporation (OTC Pink: BIEL), the maker ... the FDA panel meeting for non-thermal shortwave diathermy: ... Shortwave Therapy Meeting was held on May 21, 2013 ... focus of the meeting was very narrow, in that ... on the application of non-thermal shortwave diathermy for the ...
Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4BioElectronics and Pulsed Shortwave Therapy Make Progress 2
... 2012 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: ... China-based exporter and retailer of high-quality medical dressings and ... financial results for the first quarter of fiscal 2012, ... Quarter of Fiscal 2012 Financial Highlights , ...
... Inc. (Nasdaq: ANTH ), a biopharmaceutical company ... will release its fourth quarter 2011 financial report before ... will host a conference call at 1 pm Eastern ... also provide an update for both the varespladib and ...
Cached Medicine Technology:Winner Medical Reports First Quarter of Fiscal 2012 Results 2Winner Medical Reports First Quarter of Fiscal 2012 Results 3Winner Medical Reports First Quarter of Fiscal 2012 Results 4Winner Medical Reports First Quarter of Fiscal 2012 Results 5Winner Medical Reports First Quarter of Fiscal 2012 Results 6Winner Medical Reports First Quarter of Fiscal 2012 Results 7Winner Medical Reports First Quarter of Fiscal 2012 Results 8Winner Medical Reports First Quarter of Fiscal 2012 Results 9Winner Medical Reports First Quarter of Fiscal 2012 Results 10Winner Medical Reports First Quarter of Fiscal 2012 Results 11Winner Medical Reports First Quarter of Fiscal 2012 Results 12Winner Medical Reports First Quarter of Fiscal 2012 Results 13Winner Medical Reports First Quarter of Fiscal 2012 Results 14Winner Medical Reports First Quarter of Fiscal 2012 Results 15Winner Medical Reports First Quarter of Fiscal 2012 Results 16Winner Medical Reports First Quarter of Fiscal 2012 Results 17Winner Medical Reports First Quarter of Fiscal 2012 Results 18Anthera Announces Fourth Quarter 2011 Financial Report and Conference Call 2
... pro Electronic Pipette is ideal for all ... easy-to-follow display, ergonomically-placed operating buttons, and various ... pipetting and diluting make this a lab ... of a manual pipette without any adverse ...
... provide a complete hematology profile, including a ... aggregation. Aggregation testing is based on performing ... platelet activation, using either collagen or ADP ... and no special sample preparation is required. ...
... A complete range of automatic systems for ... 1 mL of blood. With the introduction ... the clinical diagnostic market a truly revolutionary ... technical limitation associated with the traditional ESR ...
... range of automatic systems for performing erythrocyte ... of blood. With the introduction of the ... diagnostic market a truly revolutionary testing system ... associated with the traditional ESR techique.,By means ...
Medicine Products: